Evaxion Biotech AS (EVAX)

2.57 -0.05 (-1.91%) USD  |  NASDAQ  |  Nov 08, 16:00
2.57 0.00 (0.00%) After-Hours: 16:05
More

Evaxion Biotech Research and Development Expense (% of Annual Revenues)

Research and Development Expense (% of Annual Revenues) Chart

View Research and Development Expense (% of Annual Revenues) for EVAX.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00

Historical Research and Development Expense (% of Annual Revenues) Data

View and export this data back to 2023. Upgrade now.
Date Value
December 31, 2023 --

R&D Expense Definition

R&D expense is a line item from many companies' income statements.

Read full definition.

Research and Development Expense (% of Annual Revenues) Range, Past 5 Years

Upgrade
Minimum
2023
Upgrade
Maximum
2023
Upgrade
Average
Upgrade
Median
2023

Research and Development Expense (% of Annual Revenues) Benchmarks

Ascendis Pharma AS Upgrade
Novo Nordisk AS Upgrade
DBV Technologies SA --
Adaptimmune Therapeutics PLC Upgrade
Akari Therapeutics PLC --